MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend - 2Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- 3How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- 45 Great Youngster Care Administrations To Watch in 2024
- 5AfD faction in western Germany ousts councilman for firebrand speech
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
- Vote In favor of Your Number one Cell phones
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- More parents refusing vitamin K shots for newborns, study finds
- Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- Trump administration plan to reduce access to some student loans angers nurses, health care groups
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
- Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
